All News

New data show that higher exposure to ocrelizumab (Ocrevus, Genentech) correlated with lower B-cell levels and lower rates of disability progression.

Top news of the day from across the health care landscape.

JK is experiencing gastrointestinal effects. What could be the cause?

Novartis has issued a voluntary recall of 3 lots of Promacta (eltrombopag) 12.5 mg for oral suspension to the consumer level, due to a risk of potential peanut flour contamination that occurred at a third-party contract manufacturing site.

As The Pharmacy Sage, I often write about solving your most brutal problems by asking the right questions.

Pharmacists can counsel patients on the best ways to reduce the risk of skin cancer.

Patients with HCC who have an alpha fetoprotein (AFP) of ≥ 400 ng/mL and have been previously treated with sorafenib are eligible for this treatment.

Ramucirumab (Cyramza, Eli Lilly) is approved as a single agent in patients with elevated alpha fetoprotein who have been previously treated with sorafenib.

The designation is intended to expedite the development and review of drugs for serious or life-threatening conditions when preliminary clinical evidence indicates that the drug may demonstrate substantial improvement over available therapy on one or more clinically significant endpoints.

The final guidance will provide clarity for developers who want to demonstrate that their proposed biological products meet the statutory interchangeability standard under the Public Health Service Act.

An agreement between the US Department of Health and Human Services and Gilead will provide HIV prevention drugs to uninsured individuals who are at risk.

The pathway is intended to help patients by making more treatment options available through biosimilar and interchangeable products.

This product is a generic version of Genentech's Tarceva.

Mylan Pharmaceuticals has received final approval from the FDA for its Abbreviated New Drug Application (ANDA) for Erlotinib Hydrochloride Tablets, 25 mg, 100 mg and 150 mg.

The House investigational hearing drew testimony from health care industry experts representing insurers, patient advocacy groups, and pharmaceutical companies.

Compared with interferon beta-1a, ozanimod reduced less cortical grey matter volume in patients with relapsing forms of multiple sclerosis.

An investigational therapy for amyotrophic lateral sclerosis has shown promise in slowing the progression of the disease in patients with a genetic form of the disease.

Top news of the week from Specialty Pharmacy Times.

Top news of the day from across the health care landscape.

The 17% drop is the biggest ever recorded in the United States market, according to the IQVIA Institute for Human Data Science.

Study finds the number of patients who are eligible for and may respond to checkpoint inhibitor therapies is higher than for genome-driven therapies.

Eighty-three percent of physicians excising more-than-necessary amounts of tissue on a regular basis during Mohs micrographic surgery.

Lawmakers said the generic and biosimilar manufacturers depend on the 2 databases to bring more affordable medications to the market.

Top news of the day from across the health care landscape.

According to Sandoz, the company is working to make its epinephrine 0.3 mg and 0.15 injections available to the retail market, which would enable individuals to obtain this medicine at local pharmacies.

In announcing the requirement, Health and Human Services Secretary Alex Azar said Americans deserve to know the prices of the medications they receive.

Positive results were collected from a Phase 3 study of an investigational fixed-dose combination nasal spray for the treatment of seasonal allergic rhinitis (SAR), according to Glenmark Pharmaceuticals.

Premier Inc. announced on Tuesday it is selling its specialty pharmacy business to ProCare Pharmacy LLC, a subsidiary of CVS Health Corporation.

There is no cure for multiple sclerosis, but there are more than a dozen treatment options that aid in reducing the severity of the disease.

The national retail chain is also providing a more wholesome assortment of pet foods and the company is expanding in-store veterinary clinics.